Recorded fact · drug.label_indication
drug.label_indication for palbociclib|breast-cancer
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact af720564 resolves to.
The record
| Fact id | af720564cf8bf681d68ee1b8 |
|---|---|
| Entity | drug: palbociclib|breast-cancer |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260706 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with: o an aromatase inhibitor as initial endocrine-based therapy ( 1.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: ae3bd9779c0b9ff9510de16c07e1534fc94d5d654edae2f4bad788371ecd6ee0.
The value
{
"ingredient": "PALBOCICLIB",
"conditionId": "breast-cancer",
"conditionName": "Breast Cancer",
"matchedAlias": "breast cancer",
"context": "indication",
"brand": "Ibrance",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "89a142d5-7e61-48bf-9e77-e2cd124c4792",
"labelEffectiveTime": "20260706",
"labelsRead": 3,
"labelsNaming": 3,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: d5c0ec6ac972f526632e95afb876aee038e46ad84838e1c055fc5238b0ed01d2.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.